Assignee profile:

Sanofi Pasteur Limited

City:

Toronto

Country:

Canada

Published Applications:

27

Last publication date:

2025-09-11

Patent Grants:

23

Last grant date:

2025-02-04

Top Inventors for applications by Sanofi Pasteur Limited

These are the the leading inventors for applications assigned to Sanofi Pasteur Limited:

Recent patent applications by Sanofi Pasteur Limited

Sanofi Pasteur Limited based in Toronto, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-09-11
US20250283826A1
Physics

METHODS FOR DETERMINING ADJUVANTED PROTEIN CONCENTRATION AND PERCENT ADSORPTION USING INTRINSIC FLUORESCENCE

#2 | 2022-05-05 βœ… Patent 12,214,035 granted on 2025-02-04
US20220133881A1
Human necessities

Herpesvirus compositions and related methods

#3 | 2021-01-28 βœ… Patent 12,320,753 granted on 2025-06-03
US20210025827A1
Physics

Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence

#4 | 2017-04-13
US20170102385A1
Physics

Assay for Diagnosing Streptococcus Pneumoniae

#5 | 2016-02-04
US20160032258A1
Chemistry; metallurgy

Methods for Purifying Pertussis Toxin and Peptides Useful Therefor

#6 | 2015-12-10
US20150352198A1
Human necessities

Method of Inducing And/Or Enhancing An Immune Response to Tumor Antigens

#7 | 2015-06-04 βœ… Patent 11,260,123 granted on 2022-03-01
US20150150964A1
Human necessities

Herpesvirus compositions and related methods

#8 | 2014-11-27 βœ… Patent 9,535,064 granted on 2017-01-03
US20140349863A1
Physics

Assay for diagnosing

#9 | 2013-12-26 βœ… Patent 9,327,021 granted on 2016-05-03
US20130344109A1
Human necessities

Immunogenic compositions

#10 | 2011-02-24 βœ… Patent 8,361,706 granted on 2013-01-29
US20110045502A1
Physics

Monoclonal antibodies and uses thereof

#11 | 2010-11-04 βœ… Patent 8,207,314 granted on 2012-06-26
US20100278848A1
Chemistry; metallurgy

Tumor antigens for prevention and/or treatment of cancer

#12 | 2010-11-04 βœ… Patent 8,110,199 granted on 2012-02-07
US20100278740A1
Human necessities

proteins and nucleic acid molecules

#13 | 2009-03-19 βœ… Patent 8,101,187 granted on 2012-01-24
US20090074808A1
Chemistry; metallurgy

Secreted proteins

#14 | 2008-10-23 βœ… Patent 7,713,534 granted on 2010-05-11
US20080260768A1
Human necessities

proteins and nucleic acid molecules

#15 | 2008-10-16 βœ… Patent 7,648,708 granted on 2010-01-19
US20080254070A1
Human necessities

proteins and nucleic acid molecules

#16 | 2008-07-24 βœ… Patent 7,632,515 granted on 2009-12-15
US20080175857A1
Human necessities

proteins and nucleic acid molecules

#17 | 2008-06-05 βœ… Patent 8,003,775 granted on 2011-08-23
US20080131964A1
Chemistry; metallurgy

Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics

#18 | 2008-04-17 βœ… Patent 7,722,888 granted on 2010-05-25
US20080089899A1
Human necessities

proteins and nucleic

#19 | 2007-01-30 βœ… Patent 7,169,395 granted on 2007-01-30
US9868177
-

Multivalent immunogenic composition containing RSV subunit composition and influenza virus preparation

#20 | 2007-01-23 βœ… Patent 7,166,289 granted on 2007-01-23
US10756320
-

Nucleic acid molecules encoding inclusion membrane protein C of

#21 | 2006-10-17 βœ… Patent 7,122,368 granted on 2006-10-17
US11027877
-

Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics

#22 | 2006-09-12 βœ… Patent 7,105,164 granted on 2006-09-12
US9647981
-

HIV-specific cytotoxic T-cell responses

#23 | 2006-08-29 βœ… Patent 7,098,023 granted on 2006-08-29
US11027878
-

Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics

#24 | 2006-08-01 βœ… Patent 7,083,795 granted on 2006-08-01
US8583124
-

Inactivated respiratory syncytial viral vaccines

#25 | 2006-07-04 βœ… Patent 7,070,792 granted on 2006-07-04
US10608559
-

Chlamydia antigens and corresponding DNA fragments and uses thereof

#26 | 2006-03-28 βœ… Patent 7,019,125 granted on 2006-03-28
US10334137
-

Chlamydia antigens and corresponding DNA fragments and uses thereof

#27 | 2005-08-02 βœ… Patent 6,923,970 granted on 2005-08-02
US10178488
-

Retrovirus-like particles made non-infectious by a plurality of mutations

Also check out SANOFI PASTEUR LIMITED's (Toronto, Canada) applicant profile with 5 patent applications submitted.

AssigneeID:

83583 ⎘